Melphalan / Melfalán 2mg
| Product Overview | |
| Generic Name | Melphalan / Melfalán 2mg |
| Brand Name(s) | Alkeran |
| Form | 25 oral tablets |
| Strength | 2 mg |
| Therapeutic Class | Alkylating antineoplastic agent; nitrogen mustard analogue; |
| ATC Code | L01AA03 |
| Manufacturing & Regulatory | |
| Manufacturer | Aspen, Natco, Celon, Cipla |
| Country | Mexico, Canada, USA, India |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.1756.00 |
| Free Sale Certificate | Yes, available as COPP/CPP |
| Logistics & Export | |
| MOQ | 5 bottles |
| Shelf Life | 36 months |
| Storage | Refrigerated 2°C–8°C; do not freeze; protect from light |
| Incoterms | EXW, HS/HSN 30049099 |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
| CTD Summary | CTD proprietary; available under commercial agreement/license |
Description
Melphalan is an oral cytotoxic alkylating antineoplastic agent used in selected oncology and haematology settings, particularly multiple myeloma and advanced ovarian carcinoma. It acts by damaging cellular DNA and inhibiting replication of malignant cells
